Capital Flow Monitor · Sponsors · CIK 1490953
Immunophotonics, Inc.
4340 Duncan Ave., Suite 212, ST. LOUIS, MO, 63110 · 314-501-1919
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$10.1M
% sold
—
Investors
45
Min investment
$100K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | D ·current | 506(b) | — | $10.1M | — | 45 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Alexander Michael Hurst — Executive Officer, St. Louis, MO
- Robert H. Arch — Executive Officer, St. Louis, MO
- Miguel M. Zubizarreta — Director, St. Louis, MO
- Luciano Alleruzzo — Director / Promoter, St. Louis, MO
- Jonathan Knowles — Director, St. Louis, MO, USA, MO
-
Wei Chen — Director / Promoter, St. Louis, MO
1 other raise
- Nexa AI, Inc. $1 of $1 · 100.0%
- Jacqueline Hess — Director, St. Louis, MO
- Richard Levenson — Director, St. Louis, MO
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.